Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19

BACKGROUND: The effectiveness of inhaled glucocorticoids in shortening the time to symptom resolution or preventing hospitalization or death among outpatients with mild-to-moderate coronavirus disease 2019 (Covid-19) is unclear. METHODS: We conducted a decentralized, double-blind, randomized, placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulware, David R., Lindsell, Christopher J., Stewart, Thomas G., Hernandez, Adrian F., Collins, Sean, McCarthy, Matthew William, Jayaweera, Dushyantha, Gentile, Nina, Castro, Mario, Sulkowski, Mark, McTigue, Kathleen, Felker, G. Michael, Ginde, Adit A., Dunsmore, Sarah E., Adam, Stacey J., DeLong, Allison, Hanna, George, Remaly, April, Thicklin, Florence, Wilder, Rhonda, Wilson, Sybil, Shenkman, Elizabeth, Naggie, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597427/
https://www.ncbi.nlm.nih.gov/pubmed/37733308
http://dx.doi.org/10.1056/NEJMoa2209421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597427/
https://www.ncbi.nlm.nih.gov/pubmed/37733308
http://dx.doi.org/10.1056/NEJMoa2209421

Ejemplares similares